Lieff Cabraser Heimann & Bernstein, LLP - Ortho Evra Side Effects Lawsuit
Home
About Our Firm
Our Attorneys
Contact Us
 
   
   
  Women who use the Ortho Evra birth control patch are at risk to suffer from life-threatening blood clots and strokes.  
   
  Our law firm is representing women across America with Ortho Evra injuries.  
   
  Ortho Evra is a trademark of Ortho-McNeil Pharma-
ceuticals Inc. and is used for product identification purposes only.
 


 

Ortho Evra Press Articles

2008 | 2007 | 2006 | 2005 | Timeline
The following are excerpts of news articles concerning Ortho Evra side effects and warnings. To contact an attorney at Lieff Cabraser to review your case without charge or obligation please click here, or feel free to telephone us toll-free at 1-800-541-7358 and ask to speak with attorney Heather Foster.

January 22, 2008
Globe and Mail (Canada), "More links between birth-control patch and blood-clot risk"
A new warning is being issued over the safety of the birth-control patch after a study found women on the patch are twice as likely to develop serious blood clots as those taking oral contraceptives. It's the second study in less than two years that found women using the Ortho Evra patch - marketed as Evra in Canada - face increased risks for developing blood clots, and is raising new concerns about the potential dangers of this contraceptive method. More...
 
January 19, 2008
Star-Ledger (NJ), "New label for Ortho Evra birth control patch"
The Food and Drug Administration yesterday approved an updated label for Johnson & Johnson's Ortho Evra birth control patch that gives heightened emphasis to the risk of serious blood clots some women could face. More...
 
January 18, 2008
AP, "Study links blood clots to Ortho Evra contraceptive patch"
A new study showing an increased risk of blood clots among women using a contraceptive skin patch prompted the Food and Drug Administration on Friday to add that finding to the drug's label. More...
 
January 18, 2008
FDA Safety Warning: FDA Approves Update to Label on Birth Control Patch
The U.S. Food and Drug Administration (FDA) today approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. More...
Additional Lieff Cabraser Information: Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York and Nashville, is one of the largest law firms in the United States that represents only plaintiffs. We have been nationally recognized for our representation of victims of dangerous and defective medical products. We are representing Ortho Evra birth control patch patients in individual peronal injury lawsuits.
Our clients come from across America, including the states of Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and Wyoming. Learn more about our firm.
Disclaimer: The hiring of legal professionals is an important decision that should not be based on advertising alone. Please read our attorney advertising disclaimer.
Trademark Notice: Ortho Evra is a trademark of Ortho-McNeil Pharmaceuticals Inc. and is used for product identification purposes only. The law firm of Lieff Cabraser Heimann & Bernstein, LLP, is in no way affiliated with Ortho-McNeil Pharmaceuticals Inc. or its subsidiary, Ortho Women's Health.
Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP